Table 2.

Estimated absorption dose of ¹³¹I-IFNABZA in a 73 kg adult human.

Organ	Estimated Dose (mSv/MBq−1)
Adrenals	2.76 × 10−2
Brain	3.88 × 10−3
Breasts	1.82 × 10−2
Gallbladder Wall	3.33 × 10−2
LLI Wall	2.91 × 10−2
Small Intestine	2.79 × 10−2
Stomach Wall	2.72 × 10−2
ULI Wall	2.51 × 10−2
Heart Wall	1.48 × 10−2
Kidneys	6.27 × 10−2
Liver	1.22 × 10−1
Lungs	2.25 × 10−2
Muscle	1.01 × 10−2
Ovaries	2.29 × 10−2
Pancreas	2.58 × 10−2
Red Marrow	1.80 × 10−2
Osteogenic Cells	4.92 × 10−2
Skin	1.58 × 10−2
Spleen	1.51 × 10−1
Testes	1.87 × 10−2
Thymus	1.94 × 10−2
Thyroid	1.89 × 10−2
Urinary Bladder Wall	2.18 × 10−2
Uterus	2.33 × 10−2
Whole Body	2.37 × 10−2
Effective Dose	3.02 × 10−2

Radiation-absorbed dosimetry was converted from the biodistribution of ¹³¹I-IFNABZA in 0.025 kg tumor-bearing mice to a 73 kg adult human.